Sexually transmitted infection (STI) management continues to evolve, with new treatment options, prevention strategies, and practice considerations that are important for pharmacists to understand. This course reviews recent updates in STI care, including newly approved oral therapies for gonorrhea and doxycycline post-exposure prophylaxis. You will be better prepared to recognize practice-relevant changes and support evidence-based STI prevention, treatment, and patient counseling.
HOST
Rachel Maynard, PharmD
GameChangers Podcast Host and Lead, Clinical & Partnership Education, CEimpact
GUEST
Francisco Franco, PharmD, MS, AAHIVP
Registered Store Manager,
Walgreens
GET CE FOR LISTENING!
Stay Compliant. Grow Clinically. Practice with Confidence.
Pharmacist CE Subscription: All your CE in one convenient subscription.
All episodes, CE, and Practice Resources for the GameChangers Clinical Update is included with your Pharmacist CE Subscription. But wait…there’s even more!
The Pharmacist CE Subscription includes:
- Compliance and licensure CE
- GameChangers Clinical Updates
- Practical continuing education across patient care topics
*The subscription does not include microcredentials or certificates, which are available separately for pharmacists seeking specialized service training.
PRACTICE RESOURCE
Receive the exclusive Practice Resource to use as a reference guide for this episode by purchasing the Pharmacist CE Subscription.
CPE REDEMPTION
This course is accredited for continuing pharmacy education! Click the link below that applies to you to take the exam and evaluation to claim credit:
CPE INFORMATION
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe recent updates in STI treatment and prevention that are relevant to pharmacy practice.
2. Compare emerging strategies for managing gonorrhea and STI post-exposure prophylaxis.
Rachel Maynard and Francisco Franco have no relevant financial relationships to disclose.
0.075 CEU/0.75 Hr
UAN: 0107-0000-26-241-H01-P
Initial release date: 6/22/2026
Expiration date: 6/22/2027
Additional CPE details can be found here.
